THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 108 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $462,000 | -29.8% | 31,812 | -1.4% | 0.00% | -50.0% |
| Q1 2021 | $658,000 | +12.5% | 32,260 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $585,000 | +69.6% | 32,941 | +41.1% | 0.00% | +100.0% |
| Q3 2020 | $345,000 | -31.7% | 23,354 | -3.0% | 0.00% | -50.0% |
| Q2 2020 | $505,000 | – | 24,076 | +300850.0% | 0.00% | – |
| Q1 2018 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 8 | +300.0% | 0.00% | – |
| Q2 2016 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 2 | -81.8% | 0.00% | – |
| Q3 2015 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |